Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Theragenics (TGX) on the up and up -- Ignore unavailable to you. Want to Upgrade?

To: dfloydr who wrote (833)	4/28/1998 8:43:00 PM
From: Ron Kline	Read Replies (1) \| Respond to of 1055

When I talked to investor relations I was told that using the seeds for other cancers is top priority right now to carry THRX to the next wave. Almost any localized cancer can be used with the seeds, and they see this as a big opportunity for the company. I'm curious when they will announce plans and which areas they plan to focus on. I would say that we will hear something this year for sure. I'm hoping that the clinicals, and move to market will be much quicker than it took to promote for prostate cancer. Now that they have a name and a marketing partner (who by the way owns shares of the company), it should be much smoother transition. I'm sure the market will like the news whenever they decide to announce. One thing I will say is I'm impressed with this company on how they know how to handle the investors and institutions. No hype, but just enough info to keep the street interested. Also good damage control when they had the calibration problem. Their annual report is also one of the best written out there. Ron